Melony King
Overview
Explore the profile of Melony King including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
286
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Faber M, Kjaer S, Dehlendorff C, Chang-Claude J, Andersen K, Hogdall E, et al.
Cancer Causes Control
. 2013 Mar;
24(5):989-1004.
PMID: 23456270
Purpose: The majority of previous studies have observed an increased risk of mucinous ovarian tumors associated with cigarette smoking, but the association with other histological types is unclear. In a...
2.
Obesity and risk of ovarian cancer subtypes: evidence from the Ovarian Cancer Association Consortium
Olsen C, Nagle C, Whiteman D, Ness R, Pearce C, Pike M, et al.
Endocr Relat Cancer
. 2013 Feb;
20(2):251-62.
PMID: 23404857
Whilst previous studies have reported that higher BMI increases a woman's risk of developing ovarian cancer, associations for the different histological subtypes have not been well defined. As the prevalence...
3.
Kelemen L, Bandera E, Terry K, Rossing M, Brinton L, Doherty J, et al.
BMC Cancer
. 2013 Jan;
13:28.
PMID: 23339562
Background: Studies evaluating the association between alcohol intake and ovarian carcinoma (OC) are inconsistent. Because OC and ovarian borderline tumor histologic types differ genetically, molecularly and clinically, large numbers are...
4.
Gifkins D, Olson S, Paddock L, King M, Demissie K, Lu S, et al.
BMC Cancer
. 2012 Jun;
12:211.
PMID: 22656322
Background: Limiting oxidative stress to the ovarian epithelium has been proposed as a first-line defense against ovarian cancer. Although evidence for an association between individual dietary antioxidant intake and ovarian...
5.
Bandera E, Chandran U, Buckley B, Lin Y, Isukapalli S, Marshall I, et al.
Sci Total Environ
. 2011 Oct;
409(24):5221-7.
PMID: 21975003
Background: Despite extensive research and interest in endocrine disruptors, there are essentially no epidemiologic studies of estrogenic mycotoxins, such as zeranol and zearalenone (ZEA). ZEA mycoestrogens are present in grains...
6.
Bandera E, King M, Chandran U, Paddock L, Rodriguez-Rodriguez L, Olson S
BMC Womens Health
. 2011 Sep;
11:40.
PMID: 21943063
Background: While there is extensive literature evaluating the impact of phytoestrogen consumption on breast cancer risk, its role on ovarian cancer has received little attention. Methods: We conducted a population-based...